FDA Approves Olumiant for Adolescents with Severe Alopecia Areata
FDA approves Olumiant (baricitinib) for patients aged 12 and older with severe…
FDA Grants Traditional Approval to First Complement Inhibitor for Primary IgA Nephropathy
The US FDA has granted traditional approval to Novartis' Fabhalta® (iptacopan), the…
EU Approves First Oral GLP-1 Treatment for Weight Management
The European Commission has approved Wegovy® pill as the EU's first oral…
UAE Strengthens access to innovative care with New Fibrosis Drug Approval
The Emirates Drug Establishment has approved Jascayd® (nerandomilast) for the treatment of…
UAE Approves New Oral Breast Cancer Treatment for Hormone-Resistant Cases
The UAE has approved AstraZeneca’s Etcamah, a new oral therapy for advanced…
FDA approves Lilly’s EBGLYSS® for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
The U.S. FDA has approved a new maintenance dosing regimen for Eli…
FDA Grants Priority Review for GSK’s Bepirovirsen for Chronic Hepatitis B
The FDA has granted Priority Review to GSK’s bepirovirsen for chronic hepatitis…
FDA accepts application for Roche’s Gazyva/Gazyvaro for the treatment of the most common form of lupus
The FDA has accepted Roche’s supplemental application for Gazyva/Gazyvaro as a treatment…
